Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

809126

registered interest
date	19/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Skin Diseases
house id	1
legislature	25259 pref label House of Commons
question text	What estimate he has made of the number of patients with Erythropoietic Protoporphyria.
tabling member constituency	Newport East
tabling member printed	Jessica Morden
uin	903031
answer	answer is ministerial correction date of answer 19/12/2017 answer text <p>In 2016/17 there were 54 National Health Service admissions in England with a primary diagnosis of Erythropoietic Protoporphyria.</p><p> </p><p>Whilst the numbers of people with a particular rare disease can be very small, 3.5 million people in the United Kingdom have a rare disease. We know, as with the hon. Member’s constituent, that these diseases can have a heart-breaking impact on a person’s health.</p><p> </p><p>That‘s why the UK is committed to building on our position as a world-leader in the diagnosis and treatment of rare diseases.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 19/12/2017 17:07:30 answering member 4067 label Biography information for Steve Brine
tabling member	1548 label Biography information for Jessica Morden

809129

registered interest
date	19/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS: Fees and Charges
house id	1
legislature	25259 pref label House of Commons
question text	What recent assessment he has made of trends in the level of fines in relation to dental and prescription charges.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	903036
answer	answer is ministerial correction date of answer 19/12/2017 answer text <p>The NHS Business Services Authority (NHS BSA) issues penalty charge notices (PCNs) for incorrect claims for exemption from National Health Service dental and prescription charges.</p><p>To ensure the integrity of the exemption system the NHS BSA has recently increased the number of checks. In 2016/17, 365,181 PCNs for dental charges and 975,065 for prescription charges were issued. This represents an increase of 90.11% and 90.23%, respectively, on 2015/16. There is a clear process for patients to appeal a PCN if they believe it is unjustified.</p><p> </p> answering member constituency Winchester answering member printed Steve Brine question first answered 19/12/2017 17:09:22 answering member 4067 label Biography information for Steve Brine
tabling member	4471 label Biography information for Rachael Maskell

808797

registered interest
date	18/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Prescription Drugs: Prices
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, for what reasons there was insufficient stock to confer No Cheaper Stock Obtainable (NCSO) status on a 28 pack of 5mg Amlodipine.
tabling member constituency	Fylde
tabling member printed	Mark Menzies
uin	119906
answer	answer is ministerial correction date of answer 21/12/2017 answer text <p>In November the market price of amlodipine 5mg tablets was above the reimbursement price listed in the Drug Tariff, therefore the Secretary of State for Health granted a concessionary price. Supplies of amlodipine 5mg remain available from several suppliers.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 21/12/2017 17:45:43 answering member 4067 label Biography information for Steve Brine
tabling member	3998 label Biography information for Mark Menzies

808960

registered interest
date	18/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Prescriptions: Universal Credit
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, pursuant to the Answers of the 15 November and 4 December 2017 Questions 112444, 116407 and 116409, on which date free prescription forms will be amended to include universal credit; and if he will urgently issue instructions to staff so that they do not require that universal credit claimants to declare that they are in receipt of a benefit which has not been awarded to them but instead to advise those claimants that any box on the prescription form can be ticked with the words next to it crossed out and universal credit written in their place until that benefit is named on revised prescription forms.
tabling member constituency	Birkenhead
tabling member printed	Frank Field
uin	120069
answer	answer is ministerial correction date of answer 21/12/2017 answer text <p>The Department cannot yet confirm an exact date for the revised FP10 (National Health Service prescription form) coming into circulation. The new form will be printed in 2018 and will be circulated as soon as it becomes available.</p><p> </p><p>Universal Credit claimants who meet prescribed thresholds for free prescriptions must tick the box entitled, “gets income-based Job Seeker’s Allowance”. The post exemption checking service at the NHS Business Services Authority cannot recognise Universal Credit claimants as being entitled to free prescriptions if they tick an alternative exemption category on the FP10 prescription form. If they did so, a Penalty Charge Notice could be issued.</p><p> </p><p>The current prescription exemption checking service that is in place at the NHS Business Services Authority allows the NHS to effectively tackle prescription fraud and error made by patients, and recover associated monies for the NHS.</p><p> </p><p>The Department will not make any changes to these arrangements at this time.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 21/12/2017 17:48:32 answering member 4067 label Biography information for Steve Brine
tabling member	478 label Biography information for Lord Field of Birkenhead

809017

registered interest
date	18/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Gluten-free Foods: Prescriptions
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, pursuant to the Answer of the 16 November 2017 to Question 112718, what the timetable is for the publication of a response to the consultation on the availability of gluten free foods.
tabling member constituency	Barnsley Central
tabling member printed	Dan Jarvis
uin	120126
answer	answer is ministerial correction date of answer 21/12/2017 answer text <p>It is anticipated that the consultation response will be published early in the new year.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 21/12/2017 11:53:21 answering member 4067 label Biography information for Steve Brine
tabling member	4243 label Biography information for Dan Jarvis

809057

registered interest
date	18/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Rickets: Carnforth
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, whether his Department has received any reports of rickets in the Carnforth area in the last five years.
tabling member constituency	Morecambe and Lunesdale
tabling member printed	David Morris
uin	120166
answer	answer is ministerial correction date of answer 21/12/2017 answer text <p>Information is not held in the format requested. The information available is shown in the table below. This shows a count of finished consultant episodes with a primary or secondary diagnosis of rickets, for the Lancashire Area Team of treatment, for the financial years between 2012/13 and 2016/17. The Lancashire Area Team of treatment includes the Carnforth area. Figures do not represent the number of different patients, as a person may have more than one episode of care in the same year.</p><p> </p><table><tbody><tr><td><p>Financial year</p></td><td><p>2012-13</p></td><td><p>2013-14</p></td><td><p>2014-15</p></td><td><p>2015-16</p></td><td><p>2016-17</p></td></tr><tr><td><p>Lancashire Area Team of Treatment</p></td><td><p>10</p></td><td><p>7</p></td><td><p>5</p></td><td><p>7</p></td><td><p>5</p></td></tr></tbody></table><p> </p><p>Source: Hospital Episode Statistics, NHS Digital</p> answering member constituency Winchester answering member printed Steve Brine question first answered 21/12/2017 11:54:32 answering member 4067 label Biography information for Steve Brine
tabling member	4135 label Biography information for David Morris

807191

registered interest
date	15/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Breast Cancer: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, with reference to the commercial agreement announced by NHS England on 9 November 2017, what the timetable is for NICE to issue final guidance on Perjeta (pertuzumab) in combination with Herceptin (trastuzumab) and docetaxel for HER2 positive metastatic or locally recurrent unresectable breast cancer.
tabling member constituency	North Warwickshire
tabling member printed	Craig Tracey
uin	119837
answer	answer is ministerial correction date of answer 22/12/2017 answer text <p>The timetable for the National Institute for Health and Care Excellence’s (NICE) guidance on Perjeta (pertuzumab) in combination with Herceptin (trastuzumab) and docetaxel for HER2 positive metastatic or locally recurrent unresectable breast cancer is still to be confirmed. Perjeta remains available to new and existing National Health Service patients through the Cancer Drugs Fund pending NICE’s final guidance.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 22/12/2017 11:38:14 answering member 4067 label Biography information for Steve Brine
tabling member	4509 label Biography information for Craig Tracey

806455

registered interest
date	14/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	GP at Hand: Homelessness
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, whether homeless people are able to register with the GP at hand service.
tabling member constituency	Ellesmere Port and Neston
tabling member printed	Justin Madders
uin	119531
answer	answer is ministerial correction date of answer 21/12/2017 answer text <p>Homeless patients are entitled to register with GP at Hand, in the same way as with any other general practitioner (GP) practice, using a temporary address, which may be a friend’s address or a day centre. The practice may also use the practice address to register homeless patients if they wish.</p><p> </p><p>GP at Hand offer traditional general medical services to patients registered with them. The enhanced model they are implementing now focuses on a digital first service through the use of a mobile app which is provided by Babylon Health. Due to the digital element of the service, GP at Hand may not be suitable for all patients.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 21/12/2017 16:28:20 answering member 4067 label Biography information for Steve Brine
tabling member	4418 label Biography information for Justin Madders

806468

registered interest
date	14/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Prescription Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, which prescription drugs increased proportionately the most in cost to the public purse in each of the last 10 years for which data is available.
tabling member constituency	Vale of Clwyd
tabling member printed	Chris Ruane
uin	119544
answer	answer is ministerial correction date of answer 19/12/2017 answer text <p>The information requested is presented in the table below.</p><p> </p><p>Prescription medicines have only been included where there was prescribing in both 2006 and 2016. The medicines have been ranked on the highest average annual increase from 2006 to 2016 and the top five drugs are shown at presentation level.</p><p> </p><p>Where the Net Ingredient Cost (NIC) is shown to be £0.00, this is in fact rounded and the true figure is between £0.00 and £0.01 which is calculated by dividing the NIC by quantity.</p><p> </p><p>Top five medicines with the largest average annual percentage increase, 2006-16, for NIC per quantity</p><table><tbody><tr><td><p>Drug name</p></td><td><p>NIC 2006</p></td><td><p>NIC 2016</p></td><td><p>Average annual percentage change, 2006 - 16</p></td></tr><tr><td><p>Hydrogen Peroxide Ear Drops 1.5%</p></td><td><p>£0.02</p></td><td><p>£33.28</p></td><td><p>111.1</p></td></tr><tr><td><p>Potassium Permanganate Solution 0.1%</p></td><td><p>£0.00</p></td><td><p>£1.11</p></td><td><p>102.5</p></td></tr><tr><td><p>Proflavine Solution 0.1%</p></td><td><p>£0.00</p></td><td><p>£0.42</p></td><td><p>80.1</p></td></tr><tr><td><p>Sodium Chloride Solution 0.9%</p></td><td><p>£0.00</p></td><td><p>£0.36</p></td><td><p>73.6</p></td></tr><tr><td><p>Bismuth Subgallate Suppository 300mg</p></td><td><p>£0.14</p></td><td><p>£32.97</p></td><td><p>72.9</p></td></tr></tbody></table><p>Source: Prescription Cost Analysis</p><p> </p><p> </p><p> </p> answering member constituency Winchester answering member printed Steve Brine question first answered 19/12/2017 17:25:29 answering member 4067 label Biography information for Steve Brine
tabling member	534 label Biography information for Chris Ruane

806489

registered interest
date	14/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Euratom
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department taking to ensure the future of medical supplies that are linked to the UK's membership of Euratom.
tabling member constituency	Carshalton and Wallington
tabling member printed	Tom Brake
uin	119565
answer	answer is ministerial correction date of answer 19/12/2017 answer text <p>The Government is fully aware of the importance of medical radioisotopes and the reliance on nuclear medicine for diagnostic procedures in the National Health Service. The United Kingdom’s ability to import medical isotopes from Europe and the rest of the world will not be affected by withdrawal from Euratom. It is in the interest of both the UK and the European Union to avoid disruption in the timely access of treatment to patients; and to ensure that cross-border trade with the EU is as frictionless as possible. This will be part of the broader negotiations of the UK’s future relations with the EU.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 19/12/2017 17:24:01 answering member 4067 label Biography information for Steve Brine
tabling member	151 label Biography information for Tom Brake